SCHEMBL9912585

SCHEMBL9912585

CCC(=O)Oc1ccc2ccc3c(c2c1)N=CC1(O3)N(C)c2ccccc2C1(C)C

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.74
KDM4E B2RXH2 8/20 0.74
SMN1; SMN2 Q16637 6/20 0.74
ALDH1A1 P00352 6/20 0.74
LMNA P02545 6/20 0.74
THRB P10828 5/20 0.74
GAA P10253 5/20 0.74
HTT P42858 4/20 0.74
HPGD P15428 3/20 0.74
RECQL P46063 3/20 0.74
TDP1 Q9NUW8 3/20 0.74
ALOX12 P18054 2/20 0.74
L3MBTL1 Q9Y468 2/20 0.74
POLB P06746 2/20 0.74
MAPK1 P28482 2/20 0.74
PKM P14618 3/20 0.65
NPSR1 Q6W5P4 3/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13104752 0.93 MAPT (0.62) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL20757413 0.91 MAPT (0.79) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL12588713 0.91 MAPT (0.68) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL9912635 0.91 MAPT (0.70) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL13104779 0.90 MAPT (0.64) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL13104775 0.90 MAPT (0.67) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL14444985 0.90 MAPT (0.67) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL13104745 0.90 MAPT (0.67) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL13104780 0.90 MAPT (0.69) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA
SCHEMBL13578501 0.90 MAPT (0.74) MAPTKDM4ESMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8865029-B2 Photochromic polymer and composition comprising photochromic polymer Vivimed Labs Europe Ltd. (GB) 2014-10-21 US disclosed
US-8865029-B2 Photochromic polymer and composition comprising photochromic polymer Vivimed Labs Europe Ltd. (GB) 2014-10-21 US disclosed
EP-2294114-B1 PHOTOCHROMIC POLYMER AND COMPOSITION COMPRISING PHOTOCHROMIC POLYMER ADVANCED POLYMERIK PTY LTD (AU) 2012-08-15 EP disclosed
EP-1560893-B1 PHOTOCHROMIC COMPOSITIONS AND LIGHT TRANSMISSIBLE ARTICLES ADVANCED POLYMERIK PTY LTD (AU) 2012-06-06 EP disclosed
US-20110147681-A1 Photochromic Polymer and Composition Comprising Photochromic Polymer ADVANCED POLYMERIK PTY LTD (AU) 2011-06-23 US disclosed
US-20110147681-A1 Photochromic Polymer and Composition Comprising Photochromic Polymer ADVANCED POLYMERIK PTY LTD (AU) 2011-06-23 US disclosed
US-7807075-B2 Photochromic compositions and light transmissible articles ADVANCED POLYMERIK PTY LTD (AU) 2010-10-05 US disclosed
US-7807075-B2 Photochromic compositions and light transmissible articles ADVANCED POLYMERIK PTY LTD (AU) 2010-10-05 US disclosed
WO-2009121148-A1 DYE COMPRISING FUNCTIONAL SUBSTITUENT ADVANCED POLYMERIK PTY LTD (AU) 2009-10-08 WO disclosed
US-20090093601-A1 Photochromic Compounds Comprising Polymeric Substituents And Methods For Preparation And Use Thereof POLYMERS AUSTRALIA PTY LIMITED (AU) 2009-04-09 US disclosed
US-20080006798-A1 Photochromic Compositions and Light Transmissible Articles JAMES ROBINSON SPECIALITY INGREDIENTS LTD (GB) 2008-01-10 US disclosed
US-20080006798-A1 Photochromic Compositions and Light Transmissible Articles JAMES ROBINSON SPECIALITY INGREDIENTS LTD (GB) 2008-01-10 US disclosed
US-7247262-B2 Photochromic compositions and light transmissible articles POLYMERS AUSTRALIA PTY LTD. (AU) 2007-07-24 US disclosed
US-7247262-B2 Photochromic compositions and light transmissible articles POLYMERS AUSTRALIA PTY LTD. (AU) 2007-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110147681-A1 Photochromic Polymer and Composition Comprising Photochromic Polymer SMCHD1, PCNA, PARG MAPT 94/4885KDM4E 2245/4885SMN1; SMN2 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.